Mr. Chair, I think the record shows that Canada is an attractive country for clinical trials. As I indicated, we have a very competitive regime. Special measures were put in place for COVID-related clinical trials, but otherwise, we have a competitive regime, which we are setting out to modernize. The government has invested through the budget $250 million to strengthen the clinical trials research. National networks have been established. These factors have led to the continued submission of clinical trials in Canada.
On June 7th, 2021. See this statement in context.